Population-based analysis of the risk of mycobacterial infections associated with immune checkpoint inhibitors

In this population-based study, we examined the risk of nontuberculous mycobacterial disease associated with immune checkpoint inhibitors among people with cancer. Using a nested case-control design, we identified 184 cases and 714 matched controls; there was no significant association on conditional logistic regression (adjusted odds ratio, 0.51 [95% confidence interval, .17–1.50]; P = .22).

View Source

Information

Citation

Yan M, Hernandez A, Chan KK, Stanbrook MB, Blanchette PS, Johnston JC, Lee SM, Macdonald L, Richard-Greenblatt M, Marras TK, Brode SK. Clin Infect Dis. 2025: ciae626. Epub 2025 Jan 28.

View Source

Contributing ICES Scientists

Research Programs

Populations & Public Health

Associated Topics

Associated Sites

ICES Central

Discover More

Journal Article

04/05/2025

Validation of influenza vaccination status using health administrative databases by integrating pharmacy claims and medical billing databases in Ontario, Canada

Amoud R, Kwong JC, Maxwell C, Tyas SL, Cooke M, Hernandez A, Alsabbagh W. BMC Infect Dis. 2025 May 4;25(1):653.

Journal Article

28/04/2025

SGLT2 inhibitors and risk for hyperkalemia among individuals receiving RAAS inhibitors

Wing S, Ray JG, Yau K, Jeyakumar N, Abdullah S, Luo B, Cherney DZI, Harel Z, Hundemer GL, Mavrakanas TA, Molnar AO, Odutayo A, Perl J, Young A, Charytan D, Weir M, Wald R. JAMA Intern Med. 2025; Apr 28 [Epub ahead of print].

Journal Article

23/04/2025

Real-world comparative effectiveness and safety of pertuzumab in patients with HER2+ metastatic breast cancer: a pan-Canadian population-based cohort study

Muñoz CE, Dai WF, Cheung WY, de Oliveira C, Pataky RE, Ding PQ, Tran DA, Aurangzeb Z, Nagamuthu C, Liu N, Lethbridge L, McClure C, Vriends K, Xiong H, Folkins C, Somayaji C, Peacock S, Alvi R, Turner D, O’Conaill C, McDonald T, Urquhart R, Kendell C, Dowden J, Strumpf E, Denburg A, Beca JM, Mercer RE, Tadrous M, Takhar P, Chan KKW; CanREValue Collaboration. Int J Cancer. 2025; Apr 23 [Epub ahead of print].

See All